Man’s Brain Tumor Shrinks By Half After New Form Of Therapy

A man’s brain tumor shrank by half within weeks after undergoing a new form of radioactive therapy. Paul Read (62) from Luton, became the first participant in a trial targeting glioblastoma. This is a typically fatal cancer with an average survival rate of 18 months. The new therapy involved injecting low levels of radioactivity directly into the tumour to eliminate cancer cells.